[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
作者信息
Court J, Kase J C, Mena I, Palacios E
出版信息
Rev Med Chil. 1973 Jun;101(6):452-5.
PMID:4764560
Abstract
摘要
相似文献
1
[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Rev Med Chil. 1973 Jun;101(6):452-5.
2
[Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
Wien Med Wochenschr. 1972 Jun 17;122(25):369-71.
3
[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].使用左旋多巴联合脱羧酶抑制剂治疗帕金森病
Fortschr Neurol Psychiatr Grenzgeb. 1972 Oct;40(10):564-8.
4
[Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
Acta Neurol (Napoli). 1973 Mar-Apr;28(2):208-12.
5
6
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].左旋多巴与脱羧酶抑制剂（苄丝肼，Ro 4-4602）联合治疗帕金森病的2年经验
Wien Med Wochenschr. 1974 Jun 1;124(22):340-4.
7
[Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].[联合用药（左旋多巴加脱羧酶抑制剂（Ro 8-0576））治疗帕金森病的经验]
Wien Med Wochenschr. 1973 Jun 30;123(26):433-5.
8
[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].口服左旋多巴联合脱羧酶抑制剂（Ro IV 46.02）治疗帕金森综合征
Presse Med (1893). 1969 Apr 5;77(17):619-22.
9
[Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].左旋多巴与脱羧酶抑制剂治疗帕金森综合征
Arch Invest Med (Mex). 1974;5(2):105-16.
10
[Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].
Neurol Neurocir Psiquiatr. 1969;10(1):1-25.
Zotero 插件